SANTA CLARA, California, Nov. 7, 2014 /PRNewswire/ -- CellWorld Shanghai 2014 concluded October 29 at the Intercontinental Shanghai Pudong. This year's event increased the number of delegates and participating companies to around 90 delegates from 29 companies including 3 Finesse business partners. Compared with last year, there were 10 additional companies participating in the event.
The theme was "Accelerate Your Bioprocess: Conceive, Construct, Clone." The forum introduced the Finesse cGMP-compliant SmartFactory and Finesse operations management solutions for single-use life sciences facilities. Speakers from Wuxi Apptec, Boehringer Ingelheim, Zhejiang Teruisi Pharma and IO-Consultants were invited to discuss cGMP Single-Use Facilities, implementation of perfusion processes, integration of technology transfer strategies, and new processes of life cycle management. The presentations were well received.
After the forum, Dr. Barbara Paldus, CEO of Finesse Solutions, gave an interview to Bio Equipment. She noted that Asia accounts for 25% of Finesse global business and is growing rapidly in this region, especially in China. CellWorld Shanghai was organized to serve this large market and has become a routine event in China. It provides an excellent opportunity for Finesse Solutions to meet customers and introduce new products. Dr. Paldus anticipates that CellWorld 2015 will be launched globally including the USA and Europe. CellWorld Shanghai will return in October 2015 and expects to welcome more than 100 delegates.
"Well organized… good to learn from different speaker presentations, will come back again."
Bruce, Zhejiang Teruisi Pharma
"Good event, reached my expectations, learned a lot from…experiences of other companies."
Chen Yin, T-Mab
"Good conference organization, presentation of Wuxi Apptec was good. For CellWorld Shanghai 2015, I hope the speakers can share more detailed case studies."
Michael Jiang, Henlius Pharma
"The event was good, but I hope speakers can not only just introduce what they are doing but what problems and challenges they are facing and share how those problems can be addressed by state of art technologies."
Zhang Shuxiang, BI China
About Finesse Solutions, Inc.
California-based Finesse Solutions, Inc., has a proven record of providing turn-key, scalable solutions for single-use upstream bioprocessing. The Finesse product platform includes novel disposable sensors, modular automation hardware, and intelligent software that can harmonize data and technology transfer globally. Finesse also offers a complete set of services including commissioning and validation for rapid and reliable deployment of single-use equipment. For more information, please visit us at www.finesse.com.
SOURCE Finesse Solutions, Inc.